The European Commission should shift funding towards smaller enterprises that cannot participate in Horizon 2020, says the European Parliament’s rapporteur on a new SME initiative
France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.
After the proposed Small Business Act, now it’s the turn of the European Commission’s wealthiest department – the regional policy directorate – to do its bit for SMEs.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.